Vox Markets Logo

Osirium Technologies wins regional NHS Trust contract

13:05, 20th February 2020
Francesca Morgan
Company News
TwitterFacebookLinkedIn

Cloud-based cybersecurity software firm, Osirium Technologies (AIM:OSI) FOLLOW, has won a contract with one of the UK’s largest regional NHS Trusts, the group told investors on Thursday.

The AIM-listed solution provider said that a new client, of which the name remains undisclosed, has purchased a 36 month term licence for a total of 500 devices.

Within the order, Osirium will deliver its PxM platform including the privileged access, privileged task management, and privileged session management modules.

The PxM platform has been selected in a public sector tender bid against competing bids from two other privileged access management solution providers in order to minimise the risk of security breaches in a mixed Windows and Cisco environment, the statement detailed.

Shares in Osirium Technologies were trading 4.26% higher at 24.5p during Thursday trading.

OSI price chart

"This brings another NHS Trust into our client roster and shows that Osirium is increasingly recognised as the PAM specialist best able to help these organisations address the security challenges they face,” said David Guyatt, Chief Executive of Osirium Technologies.

Drivers for the implementation include controlling access to the infrastructure by the third party contractors, vendors and service providers on whom the trust depends.

The platform will also be used to enhance security by reducing the number of privileged accounts accessed by internal staff, the company added.

“We see this as a further illustration of how NHS customers see us as strategic partners in strengthening the security of their IT operations,” Guyatt said.

The company reported bookings for the year ended 31 December 2019 to be at least £1.8m, slightly ahead of market expectations and materially ahead of the prior year.

Cash balances for the group at 31 December 2019 were £3.8m.

Follow News & Updates from Osirium Technologies here: FOLLOW

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
Watchlist